The pharmaceutical industry is spending millions of dollars to fight groups advocating lower drug costs, as criticism of high prices mounts. In some cases, self-described patient advocacy groups are receiving industry funding.
from WSJ.com: US Business http://ift.tt/2f537Uj
via IFTTT
No comments:
Post a Comment